Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer

Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer

In recent years, squamous non-small cell lung cancer (NSCLC) didn’t progress much in chemotherapy or target therapy. However, immunotherapy has made breakthroughs in treating squamous NSCLC. Immunotherapy includes two main broad classes of immune checkpoint inhibitors and therapeutic vaccines. Immun...

Full description

Bibliographic Details
Main Authors: Shouzheng WANG, Junling LI
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2016-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Immunotherapy
Checkpoint inhibitors
Tumour vaccines
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.09

Similar Items

Similar Items